JIM
GHDX

Jupiter Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Jupiter Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-85,081
Closed -$4.95M – 513
2019
Q2 		$4.95M Buy
85,081
+19,842
+30% +$1.18M 0.05% 196
2019
Q1 		$4.57M Buy
+65,239
New +$4.84M 0.04% 187
2018
Q4 		– Sell
-6,149
Closed -$431K – 467
2018
Q3 		$431K Buy
+6,149
New +$360K ﹤0.01% 317

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Jupiter Investment Management's GHDX Position: Q3 2019 in Review

Jupiter Investment Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 85,081 shares — an estimated $4.95M sold.

Jupiter Investment Management first reported a position in GHDX in Q3 2018 and held it in 3 quarters. The position peaked at $4.95M in Q2 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Jupiter Investment Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Jupiter Investment Management sold 85,081 Genomic Health, Inc. shares in Q3 2019, an estimated $4.95M.
  • Jupiter Investment Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 3 quarters.
  • Jupiter Investment Management's Genomic Health, Inc. position peaked at $4.95M in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Jupiter Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.